1. Home
  2. FINW vs PLX Comparison

FINW vs PLX Comparison

Compare FINW & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FinWise Bancorp

FINW

FinWise Bancorp

SELL

Current Price

$10.81

Market Cap

194.1M

Sector

Finance

ML Signal

SELL

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

SELL

Current Price

$2.64

Market Cap

182.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
FINW
PLX
Founded
1999
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
194.1M
182.9M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
FINW
PLX
Price
$10.81
$2.64
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $16.33
N/A
AVG Volume (30 Days)
31.9K
★ 801.0K
Earning Date
10-28-2026
08-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 21.51
N/A
EPS
★ 0.35
0.27
Revenue
N/A
★ $52,744,000.00
Revenue This Year
$41.06
$55.77
Revenue Next Year
$15.47
N/A
P/E Ratio
$30.71
★ $10.00
Revenue Growth
★ N/A
N/A
52 Week Low
$10.64
$1.65
52 Week High
$19.86
$3.19

Technical Indicators

Market Signals
Indicator
FINW
PLX
Relative Strength Index (RSI) 23.29 46.73
Support Level N/A $2.59
Resistance Level $14.55 $2.75
Average True Range (ATR) 0.29 0.10
MACD 0.05 -0.02
Stochastic Oscillator 28.72 20.00

Price Performance

Historical Comparison
FINW
PLX

About FINW FinWise Bancorp

FinWise Bancorp is an independent bank that provides a full range of banking services to individual and commercial customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: